Erlotinib

Summary

Erlotinib is an EGFR tyrosine kinase inhibitor. It’s used to treat advanced, non-small cell lung cancer with an EGFR mutation. An adverse side effect of Erlotinib is the development of rashes on the face and back.

Key Points

• Erlotinib
  • Mechanism
    • EGFR tyrosine kinase inhibitor
  • Clinical use
    • Non-small cell lung cancer
      • Advanced Non-small cell lung cancer with an EGFR mutation 
  • Adverse effects
    • Rash (nonspecific)